Overview

The Pharmacokinetics of LEO 90105 (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Extensive Psoriasis Vulgaris

Status:
Completed

Trial end date:
2012-10-01

Target enrollment:

Participant gender:

Summary

The pharmacokinetics of LEO 90105 (calcipotriol hydrate plus betamethasone dipropionate) in Japanese subjects with extensive psoriasis vulgaris.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

LEO Pharma